April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Functional Mechanisms Of Concanavalin A (cona) Induced Regulatory T Cell Suppression In Humans
Author Affiliations & Notes
  • Robert Katamay
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland
  • Baoying Liu
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland
  • Zhiyu Li
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland
  • Lai Wei
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland
  • Robert B. Nussenblatt
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland
  • Footnotes
    Commercial Relationships  Robert Katamay, Alcon Research Ltd, Novartis Stiftung (F); Baoying Liu, None; Zhiyu Li, None; Lai Wei, None; Robert B. Nussenblatt, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2929. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Robert Katamay, Baoying Liu, Zhiyu Li, Lai Wei, Robert B. Nussenblatt; Functional Mechanisms Of Concanavalin A (cona) Induced Regulatory T Cell Suppression In Humans. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2929.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Regulatory T cells play a crucial role in maintaining an immuno-balance by modifying and inhibiting the functions of CD4(+) and CD8(+) effector T cells. It is known that ConA can induce suppressor cell activities in-vitro. The goal of this study is to investigate mechanisms of induced regulatory T cell function and its possible relevance in human diseases.

Methods: : Human peripheral blood mononuclear cells (PBMCs) were isolated from the blood of healthy donors using a Ficoll gradient centrifugation protocol. T cells were sorted out and pulsed with different doses of ConA in the presence and absence of monocytes. ConA induced regulatory T cells were cocultured with PBMCs in regular wells and in transwells. Their suppressive activity was measured using CFSE and radioactive proliferation assays. Intracellular staining followed by detection with a FACS Caliber flow cytometer was used to differentiate regulatory T cell populations. Single cell real-time polymerase chain reactions and microarray analyses were used to detect mRNA expression of cytokines.

Results: : Within 48 - 60 hours ConA induces dose dependently the expression of FOXP3 in human T cells. However, only in the presence of monocytes, those CD4(+) CD25(high) CD45RA(-) FOXP3(+) induced regulatory T cells achieved suppressive potency. Their level of CD39 does not change when being activated. After being cocultured with PBMCs they show clear suppression to both CD4(+) and CD8(+) T cells. The suppression lasts for more than 108 hours. It is mediated mainly through direct T cell to T cell interactions and to a smaller degree through cytokines.

Conclusions: : During activation of T cells by ConA the presence of monocytes is necessary to induce the suppressive activity of regulatory T cells. They mediate their suppressive potency through direct T cell to T cell contact. Our data emphasize the importance of induced regulatory T cells and monocytes as regulatory players during activation.

Keywords: immunomodulation/immunoregulation • inflammation • immune tolerance/privilege 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×